Pharmaceuticals News and Research

RSS

Studies assess blood clot prevalence outside hospital prevention in hospital

More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine.

24 Jul 2007

Stop smoking ads DO help smokers quit

The more magazine ads smokers see for the nicotine patch and other quit-smoking aids, the more likely they are to try to quit smoking and be successful -- even without buying the products, finds a new Cornell study.

24 Jul 2007

Cannabis drug for MS - don't hold your breath!!

Medicine regulators have been accused of dragging their feet over a cannabis drug for people with multiple sclerosis.

23 Jul 2007

Wyeth wins case of Lisa Dean v. Wyeth

Wyeth has announced that the jury in the case of Lisa Dean v. Wyeth in U.S. District Court found in favor of Wyeth.

23 Jul 2007

Koronis Pharmaceuticals issued U.S. patent for KP-1461 therapeutic in development for treatment of HIV

Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 -- the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.

23 Jul 2007

Restless legs syndrome simulator

Restless legs syndrome (RLS) remains a common, yet often undiagnosed, neurological sensorimotor disorder, despite many years of research and increased disease recognition.

20 Jul 2007

Schering-Plough announces licensing of Acadesine

Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.

20 Jul 2007

Ortho-McNeil settles patent cases against Par/Kali

Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).

20 Jul 2007

Affiris alzheimer's vaccine in clinical trial

The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time.

19 Jul 2007

Tibotec Pharmaceuticals submits NDA for investigational HIV treatment

Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.

19 Jul 2007

Preconditioning protects brain from stroke

Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill Cornell Medical College in New York City.

18 Jul 2007

Cancer survivors share their advice in new book

Few chemotherapy patients would think to decorate their bald heads with stickers of bowling balls, or of bunny rabbits saying, "Wish you were hare."

18 Jul 2007

Research on proteases and pathological processes

A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Aviles, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations.

18 Jul 2007

Suicide gene therapy for cancer

Cutting-edge research at South Dakota State University may yield a new therapy that targets only cancer cells, leaving healthy cells unharmed.

18 Jul 2007

Nastech Pharmaceutical Co. issued patents for parathyroid hormone nasal spray for treatment of osteoporosis

Nastech Pharmaceutical Company Inc. has announced the issuance of two U.S. patents by the U.S. Patent and Trademark Office.

18 Jul 2007

Lupin receives approval for Amlodipine tablets

Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).

18 Jul 2007

Kemin files patent infringement against OmniActive

Kemin, producer of the supplement ingredient FloraGLO(R) Lutein, filed suit today in U.S. District Court for the Middle District of Florida against OmniActive Health Technologies, Inc.

18 Jul 2007

Elevated nonfasting triglyceride levels associated with heart attack

Results from two studies indicate that elevated nonfasting triglyceride levels are associated with cardiovascular events such as a heart attack, with one study finding that triglyceride levels measured after fasting does not show this association, according to studies in the July 18 issue of JAMA .

18 Jul 2007

Growth hormone for idiopathic short stature in children and adolescents

Growth hormone injections appear to boost height in extremely short, healthy children, according to a recent systematic review, but height gain appears to peak at about three inches - and those inches are expensive.

18 Jul 2007

FDA approves Extina for seborrheic dermatitis

Stiefel Laboratories, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its new drug application for Extina (ketoconazole) Foam, 2% for the treatment of seborrheic dermatitis.

18 Jul 2007